RevaCenter
The computed 12-month bankruptcy probability of RevaCenter is 0.2% (very low). The 2024 annual accounts show equity of €124k and a net result of €54k. Equity is growing by ~47.9% per year across the filed fiscal years. Its solvency ranks better than 70% of 6548 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €124k |
| Net result | €54k |
| Better than sector | 70% |
| Active | 5 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 79.9% | 66.7% | |
| Net result | €54k | €46k | |
| Equity | €124k | €79k | |
| Gross operating margin | €76k | €79k | |
| Total assets | €156k | €154k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €75k |
| Net profit | €54k |
| Cash flow | €56k |
| Staff costs | - |
| Income taxes | €19k |
| Dividends | €15k |
| Total assets | €156k |
| Equity | €124k |
| Debt | €31k |
| of which ≤ 1y | €26k |
| of which > 1y | €5k |
| Working capital | €125k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 5.74 |
| Quick ratio | 5.74 |
| Working capital ratio | 80.1% |
| Solvency | 79.9% |
| Debt / equity | 0.25 |
| Long-term debt ratio | 0.04 |
| Interest coverage | 181.48 |
| Gross margin | - |
| Net margin | - |
| ROA | 34.5% |
| ROE | 43.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €156k |
| Fixed assets | 21/28 | €5k |
| Tangible fixed assets | 22/27 | €5k |
| Current assets | 29/58 | €151k |
| Amounts receivable within one year | 40/41 | €67k |
| Cash & bank | 54/58 | €53k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €156k |
| Equity | 10/15 | €124k |
| Contributions / capital | 10/11 | €4k |
| Reserves | 13 | €120k |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €31k |
| Amounts payable after one year | 17 | €5k |
| Amounts payable within one year | 42/48 | €26k |
| Trade debts payable within one year | 44 | €13k |
| Income statement | ||
| Gross operating margin | 9900 | €76k |
| Operating result | 9901 | €73k |
| Financial income | 75 | €1 |
| Financial charges | 65 | €415 |
| Result before taxes | 9903 | €73k |
| Income taxes | 67/77 | €19k |
| Net result for the period | 9904 | €54k |
| Result to be appropriated | 9905 | €54k |
| NACE primary | Human health(86951) |
| Legal form | Private limited company(610) |
| Incorporation | 01-02-2021 |
| Status | Active |
| Postal code | 3945 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71023A0782/00H002 | Flanders | 1,018 m² | 1 · 172 m² | 9.6 m · 1 fl. |
| 71046A1576/00N000 | Flanders | 461 m² | 1 · 72 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
29-07-2025 Elien Schoofs appointed as director
- Elien Schoofs, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": "NN 95.11.14-272.22",
"name": "Elien Schoofs",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-04-01",
"evidence_quote": "Op de bijzondere algemene van 24 april 2025 met \u00E9\u00E9nparigheid van stemmen beslist om Elien Schoofs (NN 95.11.14-272.22) te benoemen als bestuurder.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "board_snapshot",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Moelans Miel",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Moelans Miel\nBestuurder",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Schoofs elien",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Schoofs elien\nBestuurder",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Antwerpen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-29",
"filing_date": "2025-04-24",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2025-04-24",
"unanimous": true
},
{
"body": "bijzondere_algemene_vergadering",
"date": "2025-04-24",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0762.756.629",
"name_full": "REVACENTER",
"legal_form": "BV"
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"verslag"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | RevaCenter |